T regulatory-1 cells induce IgG4 production by B cells: Role of IL-10

Journal of Immunology

Volumn 174, Issue 8, 2005, Pages 4718-4726

  Satoguina, Judith S ^a,b   Weyand, Esther ^b   Larbi, John ^b   Hoerauf, Achim ^a,b  

^a UNIVERSITY OF BONN   (Germany)

^b BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4;

ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CELL CULTURE; COCULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; MOLECULAR CLONING; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; T LYMPHOCYTE; TH1 CELL;

EID: 17144400762     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.8.4718     Document Type: Article

References (59)

1. Lavelle, E. C., E. McNeela, M. E. Armstrong, O. Leavy, S. C. Higgins, and K. H. Mills. 2003. Cholera toxin promotes the induction of regulatory T cells specific for bystander antigens by modulating dendritic cell activation. J. Immunol. 171:2384.
2. McGuirk, P., C. McCann, and K. H. Mills. 2002. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 195:221.
3. Higgins, S. C., E. C. Lavelle, C. McCann, B. Keogh, E. McNeela, P. Byrne, B. O'Gorman, A. Jarnicki, P. McGuirk, and K. H. Mills. 2003. Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology. J. Immunol. 171:3119.
4. + regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection and colitis in mice. J. Immunol. 170:394.
5. + t cells with regulatory properties from human blood. J. Exp. Med. 193:1303.
6. + regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells. J. Exp. Med. 196:247.
7. + regulatory T cells cure murine colitis: the role of IL-10, TGF-β, and CTLA4. J. Immunol. 171:5012.
8. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737.
9. Brattig, N. W., B. Lepping, C. Timmann, D. W. Buttner, Y. Marfo, C. Hamelmann, and R. D. Horstmann. 2002. Onchocerca volvulus-exposed persons fail to produce interferon-γ in response to O. volvulus antigen but mount proliferative responses with interleukin-5 and IL-13 production that decrease with increasing microfilarial density. J. Infect. Dis. 185:1148.
10. Hoerauf, A., and N. Brattig. 2002. Resistance and susceptibility in human onchocerciasis: beyond Th1 vs. Th2. Trends Parasitol. 18:25.
11. Steel, C., and T, B. Nutman. 2003. CTLA-4 in filarial infections: implications for a role in diminished T cell reactivity. J. Immunol. 170:1930.
12. Satoguina, J., M. Mempel, J. Larbi, M. Badusche, C. Loliger, O. Adjei, G. Gachelin, B. Fleischer, and A. Hoerauf. 2002. Antigen-specific T regulatory-1 cells are associated with immunosuppression in a chronic helminth infection (onchocerciasis). Microbes Infect. 4:1291.
13. Cottrez, F., S. D. Hurst, R. L. Coffman, and H. Groux. 2000. T regulatory cells 1 inhibit a Th2-specific response in vivo. J. Immunol. 165:4848.
14. + T cells in the control of inflammation. J. Immunol. 171:5018.
15. - T cells to acquire regulatory cell function. Blood 101:5076.
16. Atmadja, A. K., R. Atkinson, E. Sartono, F. Partono, M. Yazdanbakhsh, and R. M. Maizels. 1995. Differential decline in filaria-specific IgG1, IgG4, and IgE antibodies in Brugia malayi-infected patients after diethylcarbamazine chemotherapy. J. Infect. Dis. 172:1567.
17. Brattig, N. W., I. Krawietz, A. Z. Abakar, K. D. Erttmann, T. F. Kruppa, and A. Massougbodji. 1994. Strong IgG isotypic antibody response in sowdah type onchocerciasis. J. Infect. Dis. 170:955.
18. Aversa, G., J. Punnonen, B. G. Cocks, R. de Waal Malefyt, F. J. Vega, S. M. Zurawski, G. Zurawski, and J. E. de Vries. 1993. An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors. J. Exp. Med. 178:2213.
19. Punnonen, J., G. Aversa, B. G. Cocks, A. N. McKenzie, S. Menon, G. Zurawski, R. de Waal Malefyt, and J. E. de Vries. 1993. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. USA 90:3730.
20. de Boer, B. A., Y. C. Kruize, P. J. Rotmans, and M. Yazdanbakhsh. 1997. Interleukin-12 suppresses immunoglobulin E production but enhances immunoglobulin G4 production by human peripheral blood mononuclear cells. Infect. Immun. 65:1122.
21. Kimata, H., Y. A., Ishioka, C., Mikawa, H. 1991. Disodium cromoglycate (DSCG) selectively inhibits IgE production and enhances IgG4 production by human B cell in vitro. Clin. Exp. Immunol. 84:395.
22. Carballido, J. M., N. Carballido-Perrig, A. Oberli-Schrammli, C. H. Heusser, and K. Blaser. 1994. Regulation of IgE and IgG4 responses by allergen specific T-cell clones to bee venom phospholipase A2 in vitro. J. Allergy Clin. Immunol. 93:758.
23. Akdis, C. A., T. Blesken, M. Akdis, S. S. Alkan, B. Wuthrich, C. H. Heusser, and K. Blaser. 1997. Induction and differential regulation of bee venom phospholipase A2-specific human IgE and IgG4 antibodies in vitro requires allergen-specific and nonspecific activation of T and B cells. J. Allergy Clin. Immunol. 99:345.
24. Frew, A. I. 2003. Immunotherapy of allergic disease. J. Allergy Clin. Immunol. 111:S712.
25. Wills-Karp, M. 1999. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17:255.
26. Bellinghausen, I., J. Knop, and J. Saloga. 2001. The role of interleukin 10 in the regulation of allergic immune responses. Int. Arch. Allergy Immunol. 126:97.
27. Fellrath, J. M., A. Kettner, N. Dufour, C. Frigerio, D. Schneeberger, A. Leimgruber, G. Corradin, and F. Spertini. 2003. Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: results of a phase I trial. J. Allergy Clin. Immunol. 111:854.
28. Jutel, M., M. Akdis, F. Budak, C. Aebischer-Casaulta, M. Wrzyszcz, K. Blaser, and C. A. Akdis. 2003. IL-10 and TGF-β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur. J. Immunol. 33:1205.
29. Akdis, C. A., T. Blesken, M. Akdis, B. Wuthrich, and K. Blaser. 1998. Role of interleukin 10 in specific immunotherapy. J. Clin. Invest. 102:98.
30. Garred, P., T. E. Michaelsen, and A. Aase. 1989. The IgG subclass pattern of complement activation depends on epitope density and antibody and complement concentration. Scand. J. Immunol. 30:379.
31. Reddy, M. P., C. A. Kinney, M. A. Chaikin, A. Payne, J. Fishman-Lobell, P. Tsui, P. R. Dal Monte, M. L. Doyle, M. R. Brigham-Burke, D. Anderson, et al. 2000. Elimination of Fc receptor-dependent effector functions of a modified IgG4 monoclonal antibody to human CD4. J. Immunol. 164:1925.
32. Grogan, J. L., P. G. Kremsner, A. M. Decider, and M. Yazdanbakhsh. 1998. The effect of anti-IL-10 on proliferation and cytokine production in human schistosomiasis: fresh versus cryopreserved cells. Parasite Immunol. 20:345.
33. Akdis, C. A., and K. Blaser. 2001. Role of IL-10 in allergen-specific immunotherapy and normal response to allergens. Microbes Infect. 3:891.
34. Ottesen, E. A., F. Skvaril, S. P. Tripathy, R. W. Poindexter, and R. Hussain. 1985. Prominence of IgG4 in the IgG antibody response to human filariasis. J. Immunol. 134:2707.
35. Ottesen, E. A. 1995. Immune responsiveness and the pathogenesis of human onchocerciasis. J. Infect. Dis. 171:659.
36. + thymocytes into functionally mature Th2 cells: exogenous interleukin-12 is required for priming thymocytes to produce both Th1 cytokines and interleukin-10. Eur. J. Immunol. 26:1083.
37. Moore, K. W., A. O'Garra, R. de Waal Malefyt, P. Vieira, and T. R. Mosmann. 1993. Interleukin-10. Anna. Rev. Immunol. 11:165.
38. Del Prete, G., M. De Carli, F. Almerigogna, M. G. Giudizi, R. Biagiotti, and S. Romagnani. 1993. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 150:353.
39. Fiorentino, D. F., M. W. Bond, and T. R. Mosmann. 1989. Two types of mouse T helper cell. IV. Th2 clones secrete a factor lhat inhibits cytokine production by Th1 clones. J. Exp. Med. 170:2081.
40. Satoshi, I., A. Parswa, S. Minoru, D. Harold, V. Nancy, P. D. Raymond, C. L. Andrew, and S. F. David. 1999. Interleukin-10 inhibits expression of both interferon α- and interferon γ-induced genes by suppressing tyrosine phosphorylation of STAT1. Blood 93:1456.
41. Bellinghausen, I., G. Metz, A. H. Enk, S. Christmann, J. Knop, and J. Saloga. 1997. Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects. Eur. J. Immunol. 27:1131.
42. Groux, H., and F. Cottrez. 2003. The complex role of interleukin-10 in autoimmunity. J. Autoimmun. 20:281.
43. Levings, M. K., R. Bacchetta, U. Schulz, and M. G. Roncarolo. 2002. The role of IL-10 and TGF-β in the differentiation and effector function of T regulatory cells. Int. Arch. Allergy Immunol. 124:263.
44. Inobe, J., A. J. Slavin, Y. Komagata, Y. Chen, L. Liu, and H. L. Weiner. 1998. IL-4 is a differentiation factor for transforming growth factor-β secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Eur. J. Immunol. 28:2780.
45. Toms, C., and F. Powrie. 2001. Control of intestinal inflammation by regulatory T cells. Microbes Infect. 3:929.
46. Katakura, T., M. Miyazaki, M. Kobayashi, D. N. Heradon, and F. Suzuki. 2004. CCL17 and IL-10 as effectors that enable alternatively activated macrophages to inhibit the generation of classically activated macrophages. J. Immunol. 172:1407.
47. 2 in IL-10-mediated host immunoregulation by skin stage schistosomula of Schistosoma mansoni. J. Immunol. 165:4567.
48. Brattig, N., C. Nietz, S. Hounkpatin, R. Lucius, F. Seeber, U. Pichlmeier, and T. Pogonka. 1997. Differences in cytokine responses to Onchocerca volvulus extract and recombinant Ov33 and OvL3-1 proteins in exposed subjects with various parasitologic and clinical states. J. Infect. Dis. 176:838.
49. Caramalho, I., T. Lopes-Carvalho, D. Ostler, S. Zelenay, M. Haury, and J. Demengeot. 2003. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 192.
50. Chen, R., C. Huang, T. A. Morinelli, M. Trojanowska, and R. V. Paul. 2002. Blockade of the effects of TGF-β1 on mesangial cells by overexpression of Smad7. J. Am. Soc. Nephrol. 13:887.
51. Nakao, A., M. Afrakhte, A. Moren, T. Nakayama, J. L. Christian, R. Heuchel, S. Itoh, M. Kawabata, N. E. Heldin, C. H. Heldin, and P. ten Dijke. 1997. Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling. Nature 389:631.
52. Stock, P., O. Akbari, G. Berry, G. J. Freeman, R. H. DeKruyff, and D. T. Umetsu. 2004. Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity. Nat. Immunol. 5:1149.
53. Jutel, M., W. J. Pichler, D, Skrbic, A. Urwyler, C. Dahinden, and U. R. Muller. 1995. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen-stimulated T cell cultures. J. Immunol. 154:4187.
54. McHugh, S. M., J. Deighton, A. G. Stewart, P. J. Lachmann, and P. W. Ewan. 1995. Bee venom immunotherapy induces a shift in cytokine responses from a TH-2 to a TH-1 dominant pattern: comparison of rush and conventional immunotherapy. Clin. Exp. Allergy 25:828.
55. Pierkes, M., I. Bellinghausen, T. Hultsch, G. Metz, J. Knop, and J. Saloga. 1999. Decreased release of histamine and sulfidoleukotrienes by human peripheral blood leukocytes after wasp venom immunotherapy is partially due to induction of IL-10 and IFN-γ production of T cells. J. Allergy Clin. Immunol. 103:326.
56. Koning, H., H. J. Neijens, M. R. Baert, A. P. Oranje, and H. F. Savelkoul. 1997. T cells subsets and cytokines in allergic and non-allergic children. II. Analysis and IL-5 and IL-10 mRNA expression and protein production. Cytokine 9:427.
57. Bellinghausen, I., U. Brand, K. Steinbrink, A. H. Enk, J. Knop, and J. Saloga. 2001. Inhibition of human allergic T-cell responses by IL-10-treated dendritic cells: differences from hydrocortisone-treated dendritic cells. J. Allergy Clin. Immunol. 108:242.
58. Fu, C. L., Y. L. Ye, Y. L. Lee, and B. L. Chiang. 2003. Both allergen-specific CD4 and CD8 type 2 T cells decreased in asthmatic children with immunotherapy. Pediatr. Allergy Immunol. 14:284.
59. Nasser, S. M., S. Ying, Q. Meng, A. B. Kay, and P. W. Ewan. 2001. Interleukin-10 levels increase in cutaneous biopsies of patients undergoing wasp venom immunotherapy. Eur. J. Immunol. 31:3704.